Elsevier

Thrombosis Research

Volume 91, Issue 6, 15 September 1998, Pages 255-285
Thrombosis Research

STATE OF THE ART ARTICLE
Development and Disease in Proteinase-Deficient Mice: Role of the Plasminogen, Matrix Metalloproteinase and Coagulation System

https://doi.org/10.1016/S0049-3848(98)00122-4Get rights and content

Section snippets

The Coagulation System

Initiation of the plasma coagulation system is triggered by tissue factor (TF), which functions as a cellular receptor and cofactor for activation of the serine proteinase factor VII (FVII) to factor VIIa (FVIIa) 1, 2, 3, 4. Activation of factor VII can be performed by FVIIa (autoactivation), factor IX, factor X, factor XII, thrombin, or hepsin [2]. The TF·FVIIa complex activates factor X either directly or indirectly via activation of factor IX, resulting in the activation of prothrombin to

The Plasminogen System

The plasminogen system is composed of an inactive proenzyme plasminogen (Plg) that can be converted to plasmin by either of two plasminogen activators (PA), tissue-type PA (t-PA) or urokinase-type PA (u-PA) 29, 30. This system is controlled at the level of plasminogen activators by plasminogen activator inhibitors (PAIs) of which PAI-1 is believed to be physiologically the most important 31, 32, 33, and at the level of plasmin by a2-antiplasmin [29]. Due to its fibrin-specificity, t-PA is

Matrix Metalloproteinases

Matrix metalloproteinases (MMPs) constitute a rapidly expanding family of proteinases able to degrade most extracellular matrix components 46, 47, 48, 49. In the mouse, MMP-13 (collagenase 3) is the primary interstitial collagenase, whereas MMP-2 (gelatinase-A) and MMP-9 (gelatinase-B) degrade collagen type IV, V, VII, and X, elastin and denatured collagens. The stromelysins-1 and -2 (MMP-3 and MMP-10) and matrilysin (MMP-7) break down the proteoglycan core proteins, laminin, fibronectin,

Embryonic Hemostasis

Following initial differentiation of stem cells into endothelial cells and their assembly into endothelial cell-lined channels (vasculogenesis), the embryonic vasculature further develops via sprouting of new channels from pre-existing vessels (angiogenesis), a process that is recapitulated in adulthood during tissue neovascularization 62, 63. Once the endothelial cells are assembled into vascular channels, they become surrounded by smooth muscle cells (large vessels) or pericytes (small

Neointima Formation

Vascular interventions for the treatment of atherothrombosis induce “restenosis” of the vessel within 3–6 months in 30–50% of treated patients 119, 120. The risk and costs associated with reinterventions represent a significant medical problem, mandating a better understanding at the molecular level of this process. Arterial stenosis may result from remodelling of the vessel wall (such as occurs predominantly after balloon angioplasty) and/or from accumulation of cells and extracellular matrix

Atherosclerosis

Atherosclerotic lesions initially consist of subendothelial accumulations of foamy macrophages (fatty streaks), which subsequently develop into fibroproliferative lesions by infiltration of myofibroblasts and accumulation of extracellular matrix [145]. A fibrous cap rich in smooth muscle cells and extracellular matrix overlies a central necrotic core containing dying cells, calcifications and cholesterol crystals. As long as these lesions do not critically limit blood flow, they may grow

Graft Arterial Disease

The obstruction of the lumen due to intimal thickening (resulting from accumulation of smooth muscle cells, leukocytes and extracellular matrix, and leading to tissue ischemia) significantly limits the success of organ transplantation in a majority of patients. A mouse model of transplant arteriosclerosis has been developed, that mimics in many ways the accelerated arteriosclerosis in coronary arteries of transplanted cardiac allografts in man 140, 163. In this model, host-derived leukocytes

Myocardial Ischemia

Acute myocardial infarction due to occlusion of coronary arteries is a leading cause of morbidity and mortality in Western societies. It depresses cardiac performance, and may induce arrhythmias, infarct expansion, ventricular wall rupture, and aneurysm formation 146, 147. Although proteinases have been implicated in cardiac remodeling 164, 165, 166, 167, 168, 169, 170 and in growth and remodeling of collateral vessels [171], today, surprisingly little is known about their in vivo relevance.

Angiogenesis

Migration of endothelial cells involves proteolysis of the extracellular matrix. Quiescent endothelial cells constituvely express t- PA, MMP-2, and minimal MMP-1 29, 30, 48. Net proteolysis is, however, prevented by coincident expression of PAI-1, TIMP-1, and TIMP-2 32, 128. In contrast, when endothelial cells migrate, they significantly upregulate u-PA, u-PAR, and, to a lesser extent, t-PA at the leading edge of migration 36, 48, 129, 132, 172. Although PAI-1 is also increased, its expression

Tumor Growth and Dissemination

Pericellular plasmin proteolysis has been proposed to play a role in tumor invasion and metastasis by facilitating the migration of malignant cells through anatomical barriers via degradation of extracellular matrix constituents. Increased expression of u-PA, u-PAR, and PAI-1 by tumor cells or by the surrounding stroma has indeed been observed 201, 202, 203, 204. In addition, use of antisense mRNA, or administration of natural or synthetic serine proteinase inhibitors, u-PAR antagonists, or of

Kidney

Plasminogen activators have been implicated in renal biology [30]. u-PA is released in the urine by the epithelial cells lining the straight proximal and distal tubules, whereas t-PA is produced by glomerular cells and by epithelial cells lining the distal part of the collecting ducts [230]. Impaired fibrinolysis, resulting from reduced u-PA or increased PAI-1 activity, has been implicated in the deposition of fibrin and of extracellular matrix components in chronic renal inflammatory disorders

Infection

The expression of proteinases (in particular of the u-PA:u-PAR system) is thought to be critical for the ability of leukocytes to degrade matrix proteins and to traverse tissue planes during recruitment to inflammatory sites. u-PA has, however, also been implicated in the modulation of cytokine and growth factor expression. It is required for TNF-α expression by mononuclear phagocytes, for activation of latent TGFβ-1 [42], and may also be involved in the release of interleukin-1 (IL-1) [249].

Conclusions

Gene targeting studies are useful to obtain novel insights into the role and relevance of a gene during normal or pathological biological processes in vivo. New insights into the role of the plasminogen, matrix metalloproteinase and the coagulation system in the formation of a normal blood vessel and in its pathologic progression to disorders such as thrombosis, restenosis, and atherosclerosis have recently been obtained. Several coagulation factors appear to play an unanticipated role in the

Acknowledgements

The authors are grateful to the members of the Center for Transgene Technology and Gene Therapy and to all external collaborators who contributed to these studies.

First page preview

First page preview
Click to open first page preview

References (254)

  • Y. Wei et al.

    Identification of the urokinase receptor as an adhesion receptor for vitronectin

    J Biol Chem

    (1994)
  • H.A. Chapman

    Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration

    Curr Opin Cell Biol

    (1997)
  • N. Ferrara

    Vascular endothelial growth factor

    Trends Cardiovasc Med

    (1993)
  • P.A. Andreasen et al.

    Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes

    FEBS Lett

    (1994)
  • L.M. Matrisian

    Metalloproteinases and their inhibitors in matrix remodeling

    Trends Genet

    (1990)
  • S.S. Apte et al.

    The matrix metalloproteinase-14 (MMP-14) gene is structurally distinct from other MMP genes and is co-expressed with the TIMP-2 gene during mouse embryogenesis

    J Biol Chem

    (1997)
  • M.G. Mattei et al.

    Genes of the membrane-type matrix metalloproteinase (MT-MMP) gene family, MMP14, MMP15, and MMP16, localize to human chromosomes 14, 16, and 8, respectively

    Genomics

    (1997)
  • R. Sedlacek et al.

    Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis

    Immunobiology

    (1998)
  • M. Suzuki et al.

    Matrix metalloprotein- ase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site

    J Biol Chem

    (1997)
  • G. Preece et al.

    Metalloproteinase-mediated regulation of L-selectin levels of leukocytes

    J Biol Chem

    (1996)
  • P. Carmeliet et al.

    Vascular development and disordersMolecular analysis and pathogenetic insights

    Kidney Int

    (1998)
  • J.R. Toomey et al.

    Targeted disruption of the murine tissue factor gene results in embryonic lethality

    Blood

    (1996)
  • M. Nomura et al.

    Possible participation of autocrine and paracrine vascular endothelial gorwth factors in hypoxia-induced proliferation of endothelial cells and pericytes

    J Biol Chem

    (1995)
  • R.A. Shivdasani et al.

    Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development

    Cell

    (1995)
  • R. Ross et al.

    The biology of platelet-derived growth factor

    Cell

    (1986)
  • Z. Fan et al.

    Tissue factor regulates plasminogen binding and activation

    Blood

    (1998)
  • Z.F. Huang et al.

    Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice

    Blood

    (1997)
  • S.H. Kung et al.

    Human factor IX corrects the bleeding diathesis of mice with hemophilia B

    Blood

    (1998)
  • T.S. Edgington et al.

    The structural biology of expression and function of tissue factor

    Thromb Haemost

    (1991)
  • E.W. Davie

    Biochemical and molecular aspects of the coagulation cascade

    Thromb Haemost

    (1995)
  • G.J. Broze

    Tissue factor pathway inhibitor and the revised theory of coagulation

    Annu Rev Med

    (1995)
  • C.T. Esmon

    The protein C anticoagulant pathway

    Arterioscler Thromb

    (1992)
  • D.C. Altieri

    Xa receptor EPR-1

    FASEB J

    (1995)
  • S.R. Coughlin

    Molecular mechanisms of thrombin signaling

    Semin Hematol

    (1994)
  • S.J. Soifer et al.

    Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development

    Am J Pathol

    (1994)
  • T. Luther et al.

    Tissue factor expression during human and mouse development

    Am J Pathol

    (1996)
  • B.M. Mueller et al.

    Expression of tissue factor by melanoma cells promotes efficient hematogenous metas tasis

    Proc Natl Acad Sci USA

    (1992)
  • B.M. Mueller et al.

    Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis

    J Clin Invest

    (1998)
  • U.R. Pendurthi et al.

    Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibroblast cellsup-regulation of poly(A) polymerase

    Proc Natl Acad Sci USA

    (1997)
  • M. Masuda et al.

    Association of tissue factor with a gamma chain homodimer of the IgE receptor type I in cultured human monocytes

    Eur J Immunol

    (1996)
  • I. Ott et al.

    A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280

    J Cell Biol

    (1998)
  • M. Müller et al.

    Localization of tissue factor in membrane domains connected with force-generating components of the cytoskeleton

    Am J Pathol

    (1998)
  • Y. Sato et al.

    Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex

    Thromb Haemost

    (1997)
  • Y. Sato et al.

    Tissue factor induces migration of cultured aortic smooth muscle cells

    Thromb Haemost

    (1996)
  • Y. Zhang et al.

    Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice

    J Clin Invest

    (1994)
  • Y. Zhang et al.

    Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse Meth-A sarcomas

    J Clin Invest

    (1996)
  • J. Contrino et al.

    In situ detection of tissue factor in vascular endothelial cellsCorrelation with the malignant phenotype of human breast disease [see comments]

    Nat Med

    (1996)
  • R. Roomagi et al.

    Tissue factor expression in human non-small-cell lung carcinoma measured by immunohistochemistrycorrelation between tissue factor and angiogenesis

    Int J Cancer

    (1998)
  • W. Ruf et al.

    Tissue factor in cancer angiogenesis and metastasis

    Curr Opin Hematol

    (1996)
  • M. Shoji et al.

    Activation of coagulation and angiogenesis in cancerImmunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer

    Am J Pathol

    (1998)
  • Cited by (165)

    • Urokinase-type plasminogen activator deficiency promotes neoplasmatogenesis in the colon of mice

      2014, Translational Oncology
      Citation Excerpt :

      To date, uPA is considered as a poor prognosis factor and a potential therapeutic target for most types of cancer including colorectal cancer [15,25,26]. Transforming growth factor–β1 (TGF-β1) is one of the most important factors activated by the uPA-generated plasmin [14,27]. TGF-β1 is ubiquitously produced by a variety of cells and excreted in the extracellular matrix in a latent form.

    • Lack of both α<inf>2</inf>-antiplasmin and plasminogen activator inhibitor type-1 induces high IgE production

      2013, Life Sciences
      Citation Excerpt :

      These inhibitors regulate fibrinolysis by inhibiting plasmin and plasminogen activator activity. Besides the removal of fibrin, the fibrinolytic system may also play important roles in ovulation, embryogenesis, atherosclerosis and tissue repair as the cellular fibrinolytic system (Carmeliet and Collen, 1998). Our previous studies showed that α2-AP is associated with wound healing and fibrosis (Kanno et al., 2006, 2010).

    View all citing articles on Scopus
    View full text